Kathy Yi

Director at Theseus Pharmaceuticals Inc. (THRX), 2024-02-14
Chief Financial Officer at Cerevel Therapeutics Holdings Inc. (CERE), 2021-02-05
Evp & Chief Financial Officer at Sangamo Therapeutics Inc (SGMO), 2019-05-17

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
SGMO	$10.00	5,000	$50,000.00	25,512	2019-05-15	Filing
SGMO	$12.11	5,000	$60,550.00	25,512	2019-04-15	Filing
SGMO	$10.00	5,000	$50,000.00	25,512	2019-03-15	Filing
SGMO	$10.00	5,000	$50,000.00	25,512	2019-03-01	Filing
SGMO	$11.04	5,000	$55,200.00	7,250	2019-01-15	Filing